Treating psoriasis with adalimumab

References

• Abbott LaboratoriesAbbott Park IL. Adalimumab (Humira) package insert2004
   Google Scholar
• BreedveldFCWeismanMHKavanaughAFThe PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis Rheum200654263716385520
   PubMed Web of Science ®Google Scholar
• BurmesterGRMarietteXMontecuccoCAdalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trialAnn Rheum Dis200766732917329305
   PubMed Web of Science ®Google Scholar
• CalabreseLHMolecular differences in anticytokine therapiesClin Exp Rheumatol200321241812747285
   PubMed Web of Science ®Google Scholar
• ChaudhariURomanoPMulcahyLDEfficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trialLancet20013571842711410193
   PubMed Web of Science ®Google Scholar
• Den BroederAAvan de PutteLBARauRA single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritisJ Rheumatol20022922889812415583
   PubMed Web of Science ®Google Scholar
• FurstDESchiffMHFleischmannRMAdalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concominant standard anti-rheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)J Rheumatol20033025637114719195
   PubMed Web of Science ®Google Scholar
• GaylorMLDuvicMGeneralized pustular psoriasis following withdrawal of efalizumabJ Drugs Dermatol2004377914964752
   PubMedGoogle Scholar
• GordonKBLangleyRGLeonardiCClinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension studyJ Am Acad Dermatol199838478859520032
   PubMed Web of Science ®Google Scholar
• GottliebABEvansRLiSInfliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trialJ Am Acad Dermatol2004515344215389187
   PubMed Web of Science ®Google Scholar
• GottliebABInfliximab for psoriasisJ Am Acad Dermatol200349S1121712894134
   PubMed Web of Science ®Google Scholar
• GottliebABMathesonRTLoweNA randomized trial of etanercept as monotherapy for psoriasisArch Dermatol2003139162732 discussion, 163214676082
   PubMed Web of Science ®Google Scholar
• HeydendaelVMSpulsPIOpmeerBCMethotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasisN Engl J Med20033496586512917302
   PubMed Web of Science ®Google Scholar
• KentJPanganASzczerbakNSerious infections in patients with rheumatoid arthritis in adalimumab clinical trials200615th Congress of the European Academy of Dermatology and Venereology (EADV)Rhodes [abstract] P023.116.2006
   Google Scholar
• KreugerGKooJLebwohlMThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient membership surveyArch Dermatol2001137280411255325
   PubMedGoogle Scholar
• KruegerJGottliebAMillerBAnti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell traffickingJ Invest Dermatol200011533310951264
   PubMed Web of Science ®Google Scholar
• LeonardiCLPowersJLMathesonRTEtanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasisN Engl J Med200334920142214627786
   PubMed Web of Science ®Google Scholar
• MeasePJGoffeBSMetzJEtanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trialLancet20003563859010972371
   PubMed Web of Science ®Google Scholar
• MenterATyringSKGordonKAdalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialJ Am Acad Derm2007In press
   Google Scholar
• MorelandLWSchiffMCohenSSafety and efficacy of up to 5 years of etanercept (Enbrel) therapy in rheumatoid arthritis2002Presented at the European League Against Rheumatism12-15 June, 2002
   Google Scholar
• PappKAThe long-term efficacy and safety of new biological therapies for psoriasisArch Dermatol Res200629871516691429
   PubMed Web of Science ®Google Scholar
• PerezJKupperHOkunMOutcomes of screening for latent Tb in worldwide adalimumab clinical trials200715th Congress of the European Academy of Dermatology and Venereology (EADV)Rhodes [abstract] P035.100. 10-1-2006
   Google Scholar
• PitarchGSanchez-CarazoJLMahiquesLTreatment of Psoriasis with AdalimumabClin Exp Dermatol2006132182217305904
   PubMed Web of Science ®Google Scholar
• RauRAdalimumab (a fully human anti-tumor necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trialsAnn Rheum Dis200261suppl 2ii707312379628
   PubMedGoogle Scholar
• ReichKNestleFOPappKEXPRESS study investigators (2005) Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialLancet200536613677416226614
   PubMed Web of Science ®Google Scholar
• RoenigkHHJrAuerbachRMaibachHMethotrexate in psoriasis: consensus conferenceJ Am Acad Dermatol199838478859520032
   PubMed Web of Science ®Google Scholar
• SauratJStinglGDubertrelLCHAMPION Phase III Trial Results: Adalimumab Efficacy and Safety Compared with Methotrexate and Placebo in Patients with Moderate to Severe Psoriasis200615th Congress of the European Academy of Dermatology and Venereology (EADV)Rhodes [abstract] P035.165.2006
   Google Scholar
• SchiffMHBurmesterGRKentJDSafety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritisAnn Rheum Dis2006658899416439435
   PubMed Web of Science ®Google Scholar
• ShikiarRWillianMKOkunMMThe validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II studyHealth Qual Life Outcomes200647117005043
   PubMed Web of Science ®Google Scholar
• WinterfieldLSMenterAGordonKPsoriasis treatment: current and emerging directed therapiesAnn Rheum Dis200564Suppl 2ii879015708946
   PubMed Web of Science ®Google Scholar